8legs: American academy of neurology annual meeting

#1 out of 1100.00%

Researchers discover potential breakthrough treatment for rare condition Céline Dion lives with

New SPS therapy using CAR T-cells shows potential to treat rare stiff-person syndrome, a breakthrough discussed at a neurology conference.
Researchers say the therapy resets the immune system by depleting misbehaving B-cells and rebuilding healthy ones.
Céline Dion's 2022 SPS diagnosis links to funding that supported the new potential therapy.
Early trial results showed improved mobility four months after treatment in SPS patients.
The researchers caution that long-term durability of the therapy remains to be studied.
The SPS trial involved 26 adults and was presented at a major neurology meeting in 2026.
SPS can cause progressive muscle stiffness and difficulties with breathing, swallowing, and speaking.
CAR T-cell therapy is commonly used in cancer but is being explored for SPS in this research.
The research highlights the potential of SPS treatment to reduce dependence on walking aids.

Vote 0